Patented oral therapy for improving vision in retinal and optic nerve diseases
Protects and improves function of retinal photoreceptors and optic nerve fibres
Ultra concentrated fish oils with more than 95% EPA and DHA
Virtually no environmental toxins
Conditions
Retinitis Pigmentosa Cone-Rod dystrophy Stargardt's disease
Macular dystrophies are a group of rare inherited conditions that affect central vision in young individuals. There is currently no cure, yet there is still hope for slowing down the progression of the disease…
Read More
Wet Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of vision loss in people aged 50 or older. AMD does not lead to total blindness...
Read More
Why Eyetas
Eyetas is inspired by our long-term research and clinical practice in ophthalmology, to provide highest quality nutritional care for your eyes. It contains high concentrations of ‘essential’ Omega-3 fatty acids, namely the eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Our body is not able to produce them and therefore they must be supplied through diet. In retinal and optic nerve diseases the demand of essential Omega-3 fatty acids is high and oral supplementation is recommended to enhance tissue repair and promote regeneration.
Eyetas published pre-clinical and clinical evidence
English 
Russian